A simple blood test might reveal the earliest signs of pancreatic cancers Currently.

A simple blood test might reveal the earliest signs of pancreatic cancers Currently, disease generally found too later to save lives Reporting in a little preliminary study, Johns Hopkins researchers say a straightforward blood test predicated on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, an illness that is nearly always fatal because it isn't usually discovered until it has pass on to other areas of the physical body. The findings of their study, if confirmed, they say, could be a significant part of reducing mortality from the malignancy, which has an overall five-year survival price of significantly less than 5 % and has noticed few improvements in survival during the last three decades. We have mammograms to screen for breast tumor and colonoscopies for colon cancer but we’ve had nothing to greatly help us display for pancreatic tumor, says Nita Ahuja, M aygestin .D., a co-employee professor of medical procedures, oncology and urology at the Johns Hopkins University School of Medicine and leader of the study explained online this month in the journal Clinical Cancer Research.